Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

(2021) Tom Shimabukuro et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination

(2021) Ingrid Torjesen   BMJ-British Medical Journal

First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021

(2021) Julianne Gee et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020

(2020) Kathleen Dooling et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

The Minimum Data Set 3.0 Cognitive Function Scale

(2017) Kali S. Thomas et al.   MEDICAL CARE

Immunosenescence: Implications for response to infection and vaccination in older people

(2015) Alejandra Pera et al.   MATURITAS

Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)

(2015) Tom T. Shimabukuro et al.   VACCINE

The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety

(2014) Michael M. McNeil et al.   VACCINE

Efficient semiparametric estimation of multi-valued treatment effects under ignorability

(2009) Matias D. Cattaneo   JOURNAL OF ECONOMETRICS